Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome
Recruiting · NCT07538583 · Registry updated 2026-09-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2/3 Clinical Study of QRX003 Lotion in Subjects With Netherton Syndrome | Abnormalities, Multiple, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Ichthyosiform Erythroderma, Congenital, Infant, Newborn, Diseases, Netherton syndrome, Skin Abnormalities, Skin and Connective Tissue Diseases, hereditary disease, hereditary skin disorder, ichthyosis, keratosis, skin disorder | Recruiting | Phase 2 / Phase 3 | 2026-09-28 | NCT07538583 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Quoin Pharmaceuticals | 4 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beacon Clinical Research | Quincy | United States | 1 |
| Center for Dermatology Clinical Research | Fremont | United States | 4 |
| Dawes Fretzin Clinical Reseacrh Group | Indianapolis | United States | 1 |
| Great Ormond Street Hospital, NIHR - Clinical Research | London | United Kingdom | 1 |
| Guy's Hospital, Skin Therapy Research Unit | London | United Kingdom | 1 |
| Texas Dermatology and Laser Specialists | San Antonio | United States | 25 |
| Walsall Manor Hospital, Research & Development | Walsall | United Kingdom | 1 |
| Yale University School Of Medicine | New Haven | United States | 22 |